Appen Limited (ASX:APX)
Australia flag Australia · Delayed Price · Currency is AUD
0.9000
-0.0550 (-5.76%)
Jul 31, 2025, 4:16 PM AEST

SpringWorks Therapeutics Revenue

In the year 2024, Appen had annual revenue of $235.22M USD, down -14.09%. Appen had revenue of $121.73M in the half year ending December 31, 2024, a decrease of -40.73%.

Revenue
$235.22M
Revenue Growth
-14.09%
P/S Ratio
0.63
Revenue / Employee
$200.87K
Employees
1,171
Market Cap
238.41M

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024235.22M-38.57M-14.09%
Dec 31, 2023273.79M-114.52M-29.49%
Dec 31, 2022388.31M-58.95M-13.18%
Dec 31, 2021447.26M34.52M8.36%
Dec 31, 2020412.74M36.53M9.71%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
WiseTech Global1.13B
Xero Limited1.91B
Technology One551.68M
NEXTDC400.74M
Netwealth Group287.29M
Codan590.16M
PEXA Group380.68M
Megaport206.91M
Revenue Rankings